Background Childhood brain tumours have some of the longest time to diagnosis. A timely diagnosis may have a role in reducing anxiety in waiting for a diagnosis and subsequent morbidity and mortality. We investigated where the opportunities for an earlier diagnosis were, and for which anatomical locations this strategy will most likely to be effective. 
Introduction
Primary intracranial tumours account for 25% of all childhood cancers, and are associated with the greatest number of cancer deaths. 1 This has generated substantial interests in improving the prognosis of intracranial tumours through earlier detection, [2] [3] [4] [5] [6] [7] [8] and culminated in the identification of early diagnosis as one of the top 10 priorities for clinical research in neuro-oncology by The James Lind Alliance and by the National Cancer Research Institute Brain Supportive and Palliative Care subgroup in the United Kingdom. 9 The James Lind Alliance is a non-profit making initiative bringing together patients, carers and clinicians to identify unanswered questions that they agree are most important. 10 Evidence on early diagnosis of intracranial tumours in children and young adults, and particularly its relationship with survival, is scarce because of the logistical cost in recruiting sufficient patients to create a traditional cohort for identifying earlier diagnostic opportunities. Advances in statistical methodology and computing power in linking routinely collected patient care records have enabled creation of a population-based cohort with histologically verified intracranial tumours for examining temporal changes in the symptoms and signs at each primary care or hospital visit, thus allowing us to investigate if an earlier diagnosis of an intracranial tumour would have been possible. [11] [12] [13] [14] Our aims are to investigate if such opportunities were limited to tumours in certain locations or existed uniformly for tumours in any location to tailor recommendations on early diagnosis for specific intracranial neoplasms. This will provide evidence for a more focused approach in developing guidelines and evaluating interventions on early diagnosis to achieve the maximum possible effect in the population.
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Patients and Methods
We identified patients aged 0-24 years when diagnosed in England with a benign, borderline or malignant primary intracranial tumour from the National Cancer Registry. We have included patients up to the age of 24 years as those patients are often managed in specialist teenage cancer units in the United Kingdom.
Intracranial tumours were defined as those with a relevant morphology (diagnostic groups III, IX.b.2, IX.d.8 and X.a in the third edition of the International Classification of Childhood Cancer 15 ) and arising from one of the following sites (the 9th or 10th revision of the International Classification of Diseases, ICD 16, 17 ): the supratentorial compartment, midline, cerebellum, brainstem, ventricular system, meninges, cranial nerves and other intracranial sites. Records were excluded if they contained invalid dates or unknown sex or vital status. Records which failed Office for National Statistics validity checks, those of secondary or metastatic tumours, synchronous or multiple primary tumours were also excluded. 18 We obtained records of primary care consultations between 1989 and 2006 from Clinical Practice Research Datalink (CPRD), a database of longitudinal records of primary care consultations from over 600 practices from anywhere in the UK. 19, 20 Patient data in CPRD are representative of the UK population in age, sex and ethnicity (compared with UK Census 2011), with high level of validity in data on diagnoses (over 95% of cases confirmed in internal and external validations for neoplasms). 20, 21 We also obtained records of admissions between 1997 and 2006 from Hospital Episode Statistics (HES), which collates data on in-patient stays in National Health Service (NHS) hospitals in England. 22 CPRD and HES records were linked to the National Cancer Registry by matching on NHS number, sex, date of 6 birth and postcode. 23, 24 
Presentation rates
Over 800 clinical features relevant to an intracranial tumour presentation were identified from manually searching the list of Read and ICD-10 codes. 25 Read coding is a hierarchical system for coding symptoms, signs, diagnoses, interventions and administrative events in primary care. We retained for analysis records of primary care or hospital visits containing one or more coded features that may be explained by the presence of an underlying intracranial tumour. Each episode of hospital stay was also classified as "non-emergency" or "emergency" based on how the patient was admitted. An emergency admission came from any of the following sources: the Accident and Emergency department, general practice (direct admission or after consulting the duty hospital doctor), outpatient clinics, or by urgent transfer from another hospital.
We calculated presentation rate, which was the unit of analysis, by dividing the number of visits by observation time. Changes in the pattern of hospital presentations were estimated using a cohort of patients with linked HES records, and changes in the pattern of primary care presentations were estimated from a separate cohort of patients with linked CPRD records. The observation time for each patient in HES began on the later of the date of birth or the start date of the HES data and ended with the earlier of the date of death or the end date of HES data. The observation time in CPRD began on the date of registration with the general practice (most took place within a few weeks after birth) and ended with the earliest of the date of death, transferring out (if a patient had moved to a practice not contributing data to CPRD) or last collection date (when a practice last submitted data to CPRD). Presentation rates may thus be interpreted as the number of visits per month in a cohort of 100 patients. We described temporal changes in the presentation rates from the date of diagnosis in the National Cancer Registry for 0-1, 1-3, 3-6, 6-12 and over 12 months in the main text. 26, 27 But since time from diagnosis when patients presented is continuous in nature, we have also illustrated changes in presentation rate graphically (in supplemental materials) to overcome the arbitrariness of dividing time into intervals, especially for presentations that took place exactly at the boundary of those intervals. Although we are primarily interested in presentations before the diagnosis of an intracranial tumour, presentations after diagnosis have been included for two reasons: (a) to demonstrate, rather than to assume, that the intensity of healthcare use falls after a diagnosis and thus emphasise the importance of reaching a correct diagnosis; and (b) to reduce statistical uncertainty in estimating rates around the time of diagnosis by placing the important observations at the centre of the dataset. Estimation of rate ratios and their 95% confidence intervals was carried out in generalised linear models, with smoothing in the time domain using generalised additive models with locally weighted regression (LOESS) to highlight the underlying trend. [28] [29] [30] [31] We analysed our data in the statistical language R, with functions from the 'gam' package. 32, 33 Computationally intensive calculations were carried out on the High Performance Computing cluster at the London School of Hygiene and Tropical Medicine. elsewhere. 13 Briefly, the distributions in age and sex were similar between patients with and without linked records when compared with the National Cancer Registry, in which the data came from the general population. Tumours in the supratentorial compartment or the midline were more likely to be linked to CPRD and periventricular tumours less so. For HES linkage, cerebellar and brainstem tumours were more likely to have linked records whereas midline tumours were less likely.
Results
Primary care consultations
Consultation rates varied between tumour locations, after accounting for the effects of age and year of diagnosis (likelihood ratio test statistic = 122.8, P < 0.001).
Patients with a peri-ventricular tumour had the highest pre-diagnosis presentation frequency (mean = 11.5 consultations per 100 persons each month, Table 1 Table S .1).
Convulsion was the commonest feature of tumours in the supratentorial compartment (8.7% of consultations), ventricular system (28.0%) and meninges (27.3%). Disorders of growth or endocrine functions were common in midline tumours (15.5%).
Headaches were the dominant feature of tumours in the brainstem (7.9%), cerebellum (6.2%), midline (11.5%) and ventricles (10.0%). Dysfunction of cranial nerves II, III, IV or VI was also commonly seen in tumours in the supratentorial compartment (6.9%), midline (9.5%), ventricular system (10.0%) and cranial nerves (13.4%). Non-specific symptoms were common in brainstem (6.8%) or meninges (7.8%) tumours. Focal neurological deficits were rarely seen.
Hospital presentations
Similar to the pattern in primary care, the presentation rates varied between tumour sites after accounting for age and year of diagnosis (likelihood ratio test statistic = 106.5, P < 0.001; and for emergency presentations only: 87.2; P < 0.001). Patients with a peri-ventricular tumour were most frequently admitted to hospitals (rate = 5.4 admissions per 100 persons each month, which was 1.29 times (95% CI = 1.12-1.48) that of supratentorial tumours, Table 1) , and often as an emergency (2.5 admissions per 100 persons each month, which was 1.24 times (95% CI = 1.01-1.51) that of supratentorial tumours). Tumours outside the ventricular system presented less frequently than supratentorial tumours, with the exception of cerebellar tumours which presented as emergency with a rate 10% higher than supratentorial tumours (rate ratio = 1.10, 95% CI = 0.99-1.22).
Admissions were the most frequent within one month around the diagnosis of an intracranial tumour, with rates over 100 admissions per 100 persons each month (Supplemental Table S .2). Patients were seldom admitted urgently with any relevant symptoms until the final 3-6 months before diagnosis (Supplemental Table S 
Discussion
Children and young adults with an intracranial tumour begin presenting six months before diagnosis in primary care and three months before diagnosis in hospital.
These contacts with healthcare professionals in primary care and in hospitals represent opportunities for an earlier diagnosis.
Patients may visit Accident and Emergency with very few primary care consultations especially a non-febrile seizure, should be evaluated by a paediatrician or a physician with training and expertise in epilepsy, and referred to tertiary service for any doubtful diagnosis or treatment failure. 39 Cerebellar or brainstem tumours are expected to present commonly with loss of balance and coordination, cranial nerve dysfunction, focal neurological deficits and long-tract signs. [36] [37] [38] We found tumours in the cerebellum or the brainstem, parts of the brain close to vital structures, rarely present in primary care much earlier than when the tumours are currently diagnosed when raised intracranial pressure develops to the extent that an urgent hospital visit becomes necessary. This means the diagnosis time for posterior fossa tumours has already reached an optimal level under current technology, and the scope for further reduction is limited.
Strengths and limitations
Many studies about symptoms and signs were limited to examining a snapshot close to a diagnosis date from interviews or review of medical notes after the researchers and the patients (or their parents) were fully aware of the true diagnosis. 2-5, 40, 41 We were able to use the official diagnosis date in the National Cancer Registry, which is derived under international standards, as our end-point for the pre-diagnosis period to ensure consistency across individuals in the measurement of timing of primary care consultations and hospital visits. 26, 27 We also developed a pre-defined list of symptoms and signs to search for relevant presentations in primary care (CPRD) and hospital (HES) records to ensure comparability between different cohorts and reproducibility of our findings in future studies, especially for investigating trends in clinical care.
We were unable to examine more closely the temporal pattern of symptoms and 13 signs specific to each tumour location because of the small number of patients with linked primary care records: the population coverage of CPRD was 5-10% when our study was carried out. These have limited the certainty of our findings, but we have analysed primary care and hospital use in the largest population-based cohort of children with a histologically verified brain tumour available in England. This cohort of patients would otherwise be logistically difficult to create and follow up prospectively due to low incidence of childhood brain tumours.
Variations in the proportion of patients with linked records are due to differences in the probability of healthcare use. Tumours with a greater chance of requiring urgent interventions in hospitals (e.g. cerebellar, brainstem or peri-ventricular tumours) are found to be less likely to have presented in primary care, and therefore a linked record. The behaviour of those tumours are more fast-growing and they also originate in locations close to vital areas in the brain (brainstem) or in strategic sites that may cause life-threatening complications such as raised intracranial pressure (peri-ventricular). These two factors, in combination, reduced the chances for those tumours to be detected in primary care and contributed to the development of complications requiring urgent intervention.
The presence of a CPRD or HES record implies one or more clinical features have caused sufficient concern to the patient (or parents) to seek medical advice, and the symptoms and signs on record are those that were interpreted as important by the clinician who saw the patient. Although they may not represent the complete picture of presenting features, decisions on investigations and treatment were often made on the basis of medical records. 42, 43 Thus, CPRD and HES data are reasonably representative of the information that were used in deciding diagnosis and treatment strategy in cancer patients.
Conclusion and implications
Many patients present to primary care and hospitals with increasing frequency until 
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